Home General Biotechnology Drug Patent Expirations in January 2013

Drug Patent Expirations in January 2013

Drug Patent Expirations for January 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
LUPRON DEPOT-PEDAbbott Endocrineleuprolide acetate5,480,656Jan 2, 2013
LUPRON DEPOTAbbott Endocrineleuprolide acetate5,643,607Jan 2, 2013
LUPRON DEPOT-PEDAbbott Endocrineleuprolide acetate5,643,607Jan 2, 2013
LUPRON DEPOTAbbott Endocrineleuprolide acetate5,480,656Jan 2, 2013
TAXOTERESanofi Aventis Usdocetaxel5,750,561*PEDJan 3, 2013
TAXOTERESanofi Aventis Usdocetaxel5,698,582*PEDJan 3, 2013
TAXOTERESanofi Aventis Usdocetaxel5,714,512*PEDJan 3, 2013
ACCOLATEAstrazenecazafirlukast5,482,963Jan 9, 2013
LOTRONEXPrometheus Labsalosetron hydrochloride5,360,800Jan 13, 2013
IRESSAAstrazenecagefitinib5,616,582Jan 19, 2013
IRESSAAstrazenecagefitinib5,457,105Jan 19, 2013
MERIDIAAbbottsibutramine hydrochloride5,436,272*PEDJan 25, 2013
STARLIXNovartisnateglinide5,488,150Jan 30, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.